MARKER THERAPEUTICS, INC.: operating_income
| Value | {"amount": -19791004, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | MARKER THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:54:33.612027+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/dbaffbc7-ee70-4635-9b01-fee9218954c3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001410578-24-000297Retrieved: 2026-08-19T10:54:33.612027+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001094038/operating-income/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/dbaffbc7-ee70-4635-9b01-fee9218954c3
History
- supersedes {"amount": -29945783, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001410578-23-000324)